<VariationArchive VariationID="584310" VariationName="NC_000020.10:g.(?_61977556)_(62065276_?)del" VariationType="Deletion" Accession="VCV000584310" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2018-10-10" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="573454" VariationID="584310">
      <GeneList>
        <Gene Symbol="CHRNA4" FullName="cholinergic receptor nicotinic alpha 4 subunit" GeneID="1137" HGNC_ID="HGNC:1958" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>20q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="63343223" stop="63361349" display_start="63343223" display_stop="63361349" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="61974661" stop="61992747" display_start="61974661" display_stop="61992747" Strand="-" />
          </Location>
          <OMIM>118504</OMIM>
        </Gene>
        <Gene Symbol="KCNQ2" FullName="potassium voltage-gated channel subfamily Q member 2" GeneID="3785" HGNC_ID="HGNC:6296" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>20q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="63400208" stop="63472655" display_start="63400208" display_stop="63472655" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NT_187625.1" start="183" stop="33239" display_start="183" display_stop="33239" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="62037541" stop="62103992" display_start="62037541" display_stop="62103992" Strand="-" />
          </Location>
          <OMIM>602235</OMIM>
          <Haploinsufficiency last_evaluated="2013-07-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNQ2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-07-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNQ2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000020.10:g.(?_61977556)_(62065276_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20q13.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" innerStart="61977556" innerStop="62065276" display_start="61977556" display_stop="62065276" variantLength="87721" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.(?_61977556)_(62065276_?)del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.(?_61977556)_(62065276_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000020.10:g.(?_61977556)_(62065276_?)del AND Autosomal dominant nocturnal frontal lobe epilepsy" Accession="RCV000708464" Version="2">
        <ClassifiedConditionList TraitSetID="13216">
          <ClassifiedCondition DB="MedGen" ID="C3696898">Autosomal dominant nocturnal frontal lobe epilepsy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-07-03" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000020.10:g.(?_61977556)_(62065276_?)del AND Early infantile epileptic encephalopathy with suppression bursts" Accession="RCV001389625" Version="7">
        <ClassifiedConditionList TraitSetID="21987">
          <ClassifiedCondition DB="MedGen" ID="C0393706">Early infantile epileptic encephalopathy with suppression bursts</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-02-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-02-22" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2018-10-10" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">23360469</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2021-05-10">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="21987" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32998" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy</ElementValue>
                <XRef ID="1934" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Developmental and epileptic encephalopathy</ElementValue>
                <XRef ID="MONDO:0100062" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ohtahara syndrome</ElementValue>
                <XRef ID="1934" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Early infantile epileptic encephalopathy with suppression bursts</ElementValue>
                <XRef ID="230429005" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EIEE</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9255" />
                <XRef ID="9255" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1934" DB="Orphanet" />
              <XRef ID="C0393706" DB="MedGen" />
              <XRef ID="MONDO:0100062" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS308350" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13216" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9543" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant nocturnal frontal lobe epilepsy</ElementValue>
                <XRef ID="MONDO:0020300" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ADNFLE</ElementValue>
                <XRef ID="NBK1169" DB="GeneReviews" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11918" />
                <XRef ID="11918" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is characterized by clusters of nocturnal motor seizures, which are often stereotyped and brief (5 seconds to 5 minutes). They vary from simple arousals from sleep to dramatic, often bizarre hyperkinetic events with tonic or dystonic features. Affected individuals may experience aura. Retained awareness during seizures is common. A minority of individuals experience daytime seizures. Onset ranges from infancy to adulthood. About 80% of individuals develop ADNFLE in the first two decades of life; mean age of onset is ten years. Clinical neurologic examination is normal and intellect is usually preserved, but reduced intellect, psychiatric comorbidity, or cognitive deficits may occur. Within a family, the manifestations of the disorder may vary considerably. ADNFLE is lifelong but not progressive. As an individual reaches middle age, attacks may become milder and less frequent.</Attribute>
                <XRef ID="NBK1169" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301348</ID>
                <ID Source="BookShelf">NBK1169</ID>
              </Citation>
              <XRef ID="98784" DB="Orphanet" />
              <XRef ID="C3696898" DB="MedGen" />
              <XRef ID="MONDO:0020300" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1609600" SubmissionDate="2018-08-29" DateLastUpdated="2018-10-10" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="4501806|MedGen:CN043647" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000837574" DateUpdated="2018-10-10" DateCreated="2018-10-10" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-07-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the CHRNA4 gene has been identified. The boundaries of this event are unknown as the deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. This variant has not been reported in the literature in individuals with CHRNA4-related disease. The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in CHRNA4 cause disease. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHRNA4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.10:g.(?_61977556)_(62065276_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN043647" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4474525</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3116723" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="NM_172107.2_20_Deletion (exons 8-17)|MedGen:C0393706" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001591047" DateUpdated="2024-06-09" DateCreated="2021-05-10" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23360469</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Sub-genic deletions of exons 9-17 and exons 13-17 have been determined to be pathogenic (PMID: 23360469,¬†9425895,¬†14534157). Therefore, deletions that fully encompass that region are also expected to be pathogenic. This variant has not been reported in the literature in individuals with KCNQ2-related disease. This variant is a gross deletion of the genomic region encompassing exons 8-17 of the KCNQ2 gene. The 5' boundary is likely confined to intron 7. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated protein product or disrupt mRNA translation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.10:g.(?_61977556)_(62065276_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0393706" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3116723" TraitType="Disease" MappingType="XRef" MappingValue="C0393706" MappingRef="MedGen">
        <MedGen CUI="C0393706" Name="Early infantile epileptic encephalopathy with suppression bursts" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1609600" TraitType="Disease" MappingType="XRef" MappingValue="CN043647" MappingRef="MedGen">
        <MedGen CUI="C3696898" Name="Autosomal dominant nocturnal frontal lobe epilepsy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

